Behavioral Health Business September 4, 2024
The Drug Enforcement Administration (DEA) appears to be leaning toward releasing a rule that would put strict limits on telehealth prescribing.
However, telehealth advocates maintain that the strictness of the yet-to-be-released rule effectively makes prescribing controlled substances via telehealth impossible. If finalized, the rule that the DEA is considering would severely limit the ability of any behavioral health operator to extend access to care via telehealth.
It would also devastate the burgeoning telehealth movement in behavioral health, the advocates believe.
For certain conditions, controlled substances are key interventions. Examples include buprenorphine for opioid use disorder or mixed amphetamine salts for ADHD. And access to care and these kinds of medication has been expanded following the loosening of telehealth regulations...
Today's Sponsors
Today's Sponsor